| Size & multiples | |||
| Market Cap | $2.23B | Enterprise Value | — |
| P/E (TTM) | 22.84× | PEG (trailing) | 1.02× |
| P/S | 1.54× | P/FCF | 16.20× |
| EV/EBITDA | — | EV/EBIT | — |
| EV/Sales | — | EV/FCF | — |
| FCF Yield | 6.17% | Buyback Yield | — |
| Owner Earnings (TTM) | $108.7M | Owner Earnings Yield | 4.89% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 0.84 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 8.19% |
| After-tax Cost of Debt | 9.68% | Synthetic credit rating | AA |
| Cost of Debt · embedded (pre-tax) | 12.87% | Cost of Debt · marginal (synthetic) | 4.55% |
| WACC | 8.25% | ROIC | — |
| EVA Spread (ROIC−WACC) | — | EVA | — |
FCF runs above owner earnings — under-maintenance or a working-capital release is flattering current cash.
Synthetic rating = ICR-based credit-quality read (Damodaran), not an agency rating.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM $5.22 · revenue TTM $1.45B · FCF TTM $137.4M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Cheap vs Health Care on P/E, EV/EBITDA
P/E 47th · EV/EBITDA 46th percentile in the Health Care pool — placement read per multiple; the API emits no single blended figure, so none is shown.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| P/E | 22.8x | 24.4x | 13.0x–39.3x | 47 ↓cheap |
| EV/EBITDA | 14.5x | 15.1x | 9.8x–24.4x | 46 ↓cheap |
| FCF Yield | 4.7% | -7.8% | -34.7%–1.4% | 85 ↑strong |
| Net Margin | 6.7% | -21.2% | -325.3%–7.2% | 74 ↑strong |
| Operating Margin | 9.7% | -34.5% | -552.0%–8.0% | 77 ↑strong |
| ROE | 9.3% | -36.8% | -92.5%–4.5% | 79 ↑strong |
